High Quality Evidence of Chinese Lupus Nephritis (HELP)

Lupus Nephritis Clinical Trial

Official title: High Quality Evidence of Chinese Lupus Nephritis (HELP)

Status Recruiting

Clinical Trial Summary

The investigators are registering LN patients at recruited hospitals and developing a LN database in China. Patients will be follow-up every year, and both baseline and follow-up information will be entered into the registration system.

Clinical Trial Description

The investigators are registering Lupus nephritis (LN) and developing a LN database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education etc.), clinical characteristics (including systolic blood pressure, diastolic blood pressure, and lab measurements of whole blood, serum, urine etc.), complications, drug information at the baseline will be collected. Patients will be follow-up every year, the demographic and clinical characteristics, complications; drug information of patients will be collected at each visit. We will also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), end-stage renal disease (ESRD) or serum creatinine doubling. The patient survival and renal survival will be compared using the LN database. ;

Related Conditions & MeSH terms

• Lupus Nephritis
• Nephritis

• NCT number: NCT03001973
• Study type: Observational
• Source: Sun Yat-sen University
• Contact: Xueqing Yu, M.D. & Ph.D
• Email: yuxq@mail.sysu.edu.cn
• Status: Recruiting
• Start date: November 2013
• Completion date: December 2026